Sernova Biotherapeutics (FRA:PSH0) Total Stockholders Equity : €-13.15 Mil (As of Apr. 2025)

View and export this data going back to 2014. Start your Free Trial

What is Sernova Biotherapeutics Total Stockholders Equity?

Sernova Biotherapeutics's Total Stockholders Equity for the quarter that ended in Apr. 2025 was €-13.15 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Sernova Biotherapeutics's Book Value per Share for the quarter that ended in Apr. 2025 was €-0.04. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Sernova Biotherapeutics's Debt-to-Equity for the quarter that ended in Apr. 2025 was -0.23.

Sernova Biotherapeutics Total Stockholders Equity Historical Data

The historical data trend for Sernova Biotherapeutics's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sernova Biotherapeutics Total Stockholders Equity Chart

Sernova Biotherapeutics Annual Data

Trend

Oct15

Oct16

Oct17

Oct18

Oct19

Oct20

Oct21

Oct22

Oct23

Oct24

Total Stockholders Equity

Get a 7-Day Free Trial

2.67

19.46

35.30

8.64

-8.65

Sernova Biotherapeutics Quarterly Data
	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24	Oct24	Jan25	Apr25
Total Stockholders Equity	Get a 7-Day Free Trial															-3.75	-8.44	-8.65	-12.04	-13.15

Sernova Biotherapeutics (FRA:PSH0) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Sernova Biotherapeutics's Book Value per Share for the quarter that ended in Apr. 2025 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(-13.152	-	0)	/	328.485
	=	-0.04

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Sernova Biotherapeutics's Debt-to-Equity for the quarter that ended in Apr. 2025 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(2.241	+	0.775)	/	-13.152
	=	-0.23

Sernova Biotherapeutics Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Sernova Biotherapeutics's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Sernova Biotherapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sernova Biotherapeutics Inc (FRA:PSH0) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

SEOVF:USA PSH0:Germany SVA:Canada

Address

700 Collip Circle, Suite 114, London, ON, CAN, N6G 4X8

Website

https://www.sernova.com

Sernova Biotherapeutics Inc is a clinical-stage company developing regenerative medicines. The company develops Cell Pouch with human donor cells or stem cells to create a biohybrid organ. The Cell Pouch is a implantable medical device designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells, which then release proteins, hormones, or other factors into the bloodstream for the long-term treatment of multiple chronic diseases such as type 1 diabetes, hypothyroid disease, and rare diseases such as hemophilia A.

Sernova Biotherapeutics Headlines

No Headlines